| Literature DB >> 26879647 |
George W Preston1, David H Phillips2.
Abstract
Absolute quantification of peptides is typically achieved using amino acid analysis, elemental analysis or derivatisation chemistry. Impurities, if present, may be accounted for using analytical high-performance liquid chromatography (HPLC) with detection of the peptide bond ultraviolet (UV) absorbance. To do this, peak areas from a UV chromatogram are used to estimate percentage purity on a mass basis, and this purity value is used as a correction. However, because the approach assumes that UV absorbance is uniformly proportional to mass, the result may be only semi-quantitative. Here, an alternative approach involving HPLC with detection of intrinsic tyrosine fluorescence is described. The fluorescence properties of a 21-residue synthetic peptide corresponding to an S-carbamidomethylated tryptic fragment of human serum albumin were characterised, and a method involving quantification relative to a non-peptidic calibrant, N-acetyl-L-tyrosine ethyl ester, was established. The method was used to quantify the thiol form of the peptide, and the results were compared with a parallel analysis involving derivatisation of the same material with Ellman's reagent. When differences in fluorescence response (analyte versus calibrant) were accounted for, the measurements obtained via the two methods were in good agreement. Contributions from peptidic impurities were also considered, and their influence on the validity of the conclusions was evaluated. Despite some ambiguities introduced by the impurities, and the identification of some other potential sources of error, the results demonstrate that use of Tyr fluorescence is a promising solution to the challenging problem of absolute peptide quantification.Entities:
Keywords: Amino acids/peptides; Fluorescence/luminescence; Genomics/proteomics; HPLC
Mesh:
Substances:
Year: 2016 PMID: 26879647 PMCID: PMC4799795 DOI: 10.1007/s00216-016-9334-1
Source DB: PubMed Journal: Anal Bioanal Chem ISSN: 1618-2642 Impact factor: 4.142
Column assemblies used for reversed-phase HPLC of peptides and Ac-Tyr-OEt
| Column assembly | Column 1a | Column 2a | ||||
|---|---|---|---|---|---|---|
| Product no. | Length (mm) | I.D. (mm) | Product no. | Length (mm) | I.D. (mm) | |
| A | 568472-U | 20 | 4.0 | 568421-U | 100 | 4.6 |
| B | 568472-U | 20 | 4.0 | – | – | – |
| C | 568472-U | 20 | 4.0 | 568420-U | 50 | 4.6 |
| D | 568421-U | 100 | 4.6 | – | – | – |
| E | 568423-U | 250 | 4.6 | – | – | – |
| F | 568472-U | 20 | 4.0 | 568472-U | 20 | 4.0 |
Product numbers correspond to entries in the Sigma-Aldrich catalogue
I.D. inner diameter
aFor pairwise combinations, numbering corresponds to the order of serially connected columns in the direction of flow
Fig. 1Absorption and fluorescence spectra of a Ac-Tyr-OEt and b Cam-iT3. Normalised intensity is relative to the peak of interest. For the fluorescence excitation spectrum (dashed line), λ em was 312 nm; for the emission spectrum (solid line), λ ex was 278 nm
Fig. 2Analysis of fluorescent components in a commercial preparation of iT3: a chromatogram from HPLC-FDTyr. iT3 accounts for the majority of the observed fluorescence, but extraneous peaks (E1–E3) were also present. In this experiment, two fractions (1 and 2) were collected. b ESI mass spectra from infusion of the two fractions. Components E1 and E2 were analysed in a separate experiment (see ESM)